After its IPO CAEL announced that it has entered to purchase 1,030,167 of its own common stock shares in a privately negotiated transaction for a price tag of $8,210,430.99 from a stockholder who otherwise intended to vote against the previously announced planned business combination among Camden and Dlorah, Inc. The purchase of these shares will take place during or directly following the finishing of the transaction with Dlorah. the purchase will be paid for with money that will be allowed to be withdrawn from Camden’s trust account leading consummation of the transaction with Dlorah.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
About Camden Learning Corporation
Camden is a special purpose acquisition company formed in 2007 for the purpose of acquiring through a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination one or more businesses or assets. Camden’s initial public offering was consummated on December 5, 2007 and it received net proceeds of approximately $53 million through the sale of 6,250,000 units, including 376,300 units pursuant to the underwriters’ over-allotment option, at $8.00 per unit. Each unit is comprised of one share of Camden common stock and one warrant with an exercise price of $5.50. As of August 31, 2009, Camden held approximately $52.5 million (or approximately $7.92 per share) in a trust account maintained by an independent trustee, which will be released upon the consummation of the transaction.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
